Stockscreener 앱 받기
2.12
2.91%
0.0599
시간 외 거래:
2.12
전일 마감가:
$2.0601
열려 있는:
$2.08
하루 거래량:
5,049
Relative Volume:
0.32
시가총액:
$78.23M
수익:
-
순이익/손실:
-
주가수익비율:
-0.8414
EPS:
-2.5197
순현금흐름:
-
1주 성능:
+2.91%
1개월 성능:
-21.05%
6개월 성능:
-39.43%
1년 성능:
-76.78%
1일 변동 폭
$2.08
$2.14
1주일 범위
$1.92
$2.1835
52주 변동 폭
$1.85
$17.48
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
ANL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANL
Adlai Nortye Ltd Adr
|
2.12 | 78.23M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-04 | 개시 | H.C. Wainwright | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr 주식(ANL)의 최신 뉴스
Adlai Nortye Announces CFO Transition with Interim Appointment - TipRanks
Trump Announces Nomination of Howard Lutnick to Serve as US Commerce Secretary, to Run Office of US Trade Representative - AASTOCKS.com
Adlai Nortye shares hold Buy rating by H.C. Wainwright on oncology programs - Investing.com
Adlai Nortye stock strengthened by oncology trial results, H.C. Wainwright keeps at Buy list - Investing.com
ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com
ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa
Adlai Nortye stock plunges to 52-week low of $1.89 - Investing.com
Adlai Nortye stock plunges to 52-week low of $1.89 By Investing.com - Investing.com Canada
Adlai Nortye Ltd. Sponsored ADR (ANL) Loses -33.06% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
H.C. Wainwright sees upside in Adlai Nortye stock amid robust oncology pipeline - Investing.com
Adlai Nortye Reports Strong 2024 Mid-Year Results - TipRanks
Adlai Nortye releases unaudited H1 2024 results, adds new director - Investing.com
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
Adlai Nortye (ANL) Stock Price, News & Analysis - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Adlai Nortye Ltd Adr (ANL) 재무 분석
Adlai Nortye Ltd Adr (ANL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.95%
2.39%
자본화:
|
볼륨(24시간):